Unbelievable, page-13

In my opinion Mongy has continued to give a balanced view of this company with a realistic view of the risks it faced.
I was keen to buy around the time of the failed CR. But his assessments seemed realistic and well researched.
It is easy to become wed to a stock, which has potential, and focus only on that. That investing behaviour cost me heaps in a certain biotech company. I have learned from that the value of risk/reward assessment.(emphasis on risk)
I for one am very grateful to Mongy..........